Concepedia

Inflammatory Biomarkers in Assessing Severity and Prognosis of Immune Checkpoint Inhibitor-Associated Cardiotoxicity

Lin Liang, Chanjuan Cui, Dan Lv, Yiqun Li, Liyan Huang, Jiayu Feng, Tao An, Pengchao Tian, K. G. Yang, Linjun Hu,

ESC Heart Failure · 2023 · 19 citations · 25 references

DOIFull text

Open access

Abstract

In patients who develop iRCs, NER is significantly elevated at iRC onset, and higher NER correlates with greater iRC severity and higher mortality. Larger datasets are needed to validate these findings.

References

25

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.6K citations · Full text

, , +15

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal · 2022 · 2.4K citations · Full text

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley et al. · Annals of Oncology · 2020 · 950 citations · Full text

, , +11

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

Benjamin Weide, Alexander Martens, Jessica C. Hassel et al. · Clinical Cancer Research · 2016 · 569 citations · Full text

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 549 citations · Full text